-+ 0.00%
-+ 0.00%
-+ 0.00%
MetaVia to Present DA-1726 Phase 1 Trial Data at Precision Liver Symposium
Share
Listen to the news
MetaVia to Present DA-1726 Phase 1 Trial Data at Precision Liver Symposium
  • MetaVia will present Phase 1 trial results for DA-1726 at the Precision Liver Symposium on November 4, 2026, in Denver.
  • The randomized, placebo-controlled trial showed significant reductions in liver fat and weight, with relative preservation of lean mass.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610280831PR_NEWS_USPR_____NY82637) on October 28, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending